Lumacaftor/ivacaftor-associated health stabilisation in adults with severe cystic fibrosis Source: ERJ Open Res, 7 (1) 00203-2020; 10.1183/23120541.00203-2020 Year: 2021
Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 51 (6) 1702509; 10.1183/13993003.02509-2017 Year: 2018
Risk factors for lung disease progression in children with cystic fibrosis Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018 Year: 2018
Impact of other risk factors than age at diagnosis on outcome in cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals Source: ERJ Open Res, 6 (3) 00294-2019; 10.1183/23120541.00294-2019 Year: 2020
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe Source: ERJ Open Res, 7 (4) 00411-2021; 10.1183/23120541.00411-2021 Year: 2021
Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011
Evaluation of disease knowledge in children with cystic fibrosis and their families Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011
Prevalence of anxiety and association with health related quality of life in adult patients with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020
A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021
Factors influencing exercise performance in adults with cystic fibrosis Source: Annual Congress 2010 - Physical activity, exercise regimes and outcomes for chronic respiratory disease Year: 2010
Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood Source: Virtual Congress 2020 – Respiratory diseases in children and adults Year: 2020
The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease Source: Eur Respir Rev, 29 (155) 190112; 10.1183/16000617.0112-2019 Year: 2020
Hospital admissions are linked to a poor health related quality of life in patients with non cystic fibrosis bronchiectasis Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007
Potential risk factors for poor outcomes post-lung transplant for cystic fibrosis Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019
Prevalence of tracheobronchomalacia in young children with cystic fibrosis Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012
Assessment of mental health status in primary ciliary dyskinesia and cystic fibrosis patients and their parents Source: International Congress 2018 – Cystic fibrosis in adults: current research Year: 2018